Please use this identifier to cite or link to this item:
https://hdl.handle.net/10316/104749
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ożarowski, Marcin | - |
dc.contributor.author | Karpiński, Tomasz M. | - |
dc.contributor.author | Zielińska, Aleksandra | - |
dc.contributor.author | Souto, Eliana B. | - |
dc.contributor.author | Wielgus, Karolina | - |
dc.date.accessioned | 2023-01-24T11:06:40Z | - |
dc.date.available | 2023-01-24T11:06:40Z | - |
dc.date.issued | 2021-04-21 | - |
dc.identifier.issn | 1422-0067 | pt |
dc.identifier.uri | https://hdl.handle.net/10316/104749 | - |
dc.description.abstract | As the major nonpsychotropic constituent of Cannabis sativa, cannabidiol (CBD) is regarded as one of the most promising therapeutic agents due to its proven effectiveness in clinical trials for many human diseases. Due to the urgent need for more efficient pharmacological treatments for several chronic diseases, in this review, we discuss the potential beneficial effects of CBD for Alzheimer's disease, epilepsy, multiple sclerosis, and neurological cancers. Due to its wide range of pharmacological activities (e.g., antioxidant, anti-inflammatory, and neuroprotective properties), CBD is considered a multimodal drug for the treatment of a range of neurodegenerative disorders, and various cancer types, including neoplasms of the neural system. The different mechanisms of action of CBD are here disclosed, together with recent progress in the use of this cannabis-derived constituent as a new therapeutic approach. | pt |
dc.language.iso | eng | pt |
dc.publisher | MDPI | pt |
dc.relation | Institute of Human Genetics, Polish Academy of Sciences by the internal grant for the implementation of a single scientific activity and by the National Centre for Research and Development by the grant ONKOKAN, INNOMED/I/11/NCBR/2014. | pt |
dc.rights | openAccess | pt |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | pt |
dc.subject | Cannabis sativa | pt |
dc.subject | cannabidiol | pt |
dc.subject | CBD | pt |
dc.subject | mechanism of action | pt |
dc.subject | Alzheimer’s disease | pt |
dc.subject | epilepsy | pt |
dc.subject | multiple sclerosis | pt |
dc.subject | cancer | pt |
dc.subject | pharmacological activity | pt |
dc.subject.mesh | Animals | pt |
dc.subject.mesh | Anticonvulsants | pt |
dc.subject.mesh | Cannabidiol | pt |
dc.subject.mesh | Humans | pt |
dc.subject.mesh | Neoplasms | pt |
dc.subject.mesh | Nervous System Diseases | pt |
dc.title | Cannabidiol in Neurological and Neoplastic Diseases: Latest Developments on the Molecular Mechanism of Action | pt |
dc.type | article | - |
degois.publication.firstPage | 4294 | pt |
degois.publication.issue | 9 | pt |
degois.publication.title | International Journal of Molecular Sciences | pt |
dc.peerreviewed | yes | pt |
dc.identifier.doi | 10.3390/ijms22094294 | pt |
degois.publication.volume | 22 | pt |
dc.date.embargo | 2021-04-21 | * |
uc.date.periodoEmbargo | 0 | pt |
item.fulltext | Com Texto completo | - |
item.languageiso639-1 | en | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.openairetype | article | - |
item.grantfulltext | open | - |
item.cerifentitytype | Publications | - |
crisitem.author.orcid | 0000-0003-2603-1377 | - |
crisitem.author.orcid | 0000-0002-9737-6017 | - |
Appears in Collections: | FFUC- Artigos em Revistas Internacionais |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Cannabidiol-in-neurological-and-neoplastic-diseases-Latest-developments-on-the-molecular-mechanism-of-actionInternational-Journal-of-Molecular-Sciences.pdf | 1.21 MB | Adobe PDF | View/Open |
WEB OF SCIENCETM
Citations
26
checked on Jul 2, 2024
Page view(s)
69
checked on Jul 23, 2024
Download(s)
105
checked on Jul 23, 2024
Google ScholarTM
Check
Altmetric
Altmetric
This item is licensed under a Creative Commons License